What is LDL / HDL Ratio?
The LDL/HDL ratio divides LDL cholesterol by HDL cholesterol to give a single-number summary of the balance between atherogenic transport (LDL) and reverse transport back to the liver (HDL). A higher ratio means more atherogenic cholesterol per unit of protective cholesterol, and that pattern tracks with increased cardiovascular risk in epidemiological studies. The ratio is not a direct measurement but a derived value: it is calculated from two figures that each carry their own uncertainty. Historically, the LDL/HDL ratio — alongside the total/HDL ratio — was one of the most widely used summaries in risk calculations, particularly in Framingham-derived tools. Recent European and Dutch guidelines have largely replaced it with non-HDL cholesterol and ApoB as better measures, because those capture all atherogenic particles without dividing by the protective fraction. The ratio remains widely reported, however, and is useful as a quick trend indicator. The value has no fixed unit — it is a dimensionless quotient. As a general guide, a ratio below 3.0–3.5 is considered favourable for most adults; above 4.0–5.0 risk is regarded as elevated. Exact cut-offs vary between guidelines and risk models, and the ratio is always a supporting tool, not a diagnosis.
Why is LDL / HDL Ratio relevant?
The LDL/HDL ratio is useful as a quick lipid profile summary, particularly when tracking changes after a lifestyle intervention or the start of medication. When LDL falls and HDL rises — the desired pattern with improved metabolic health or statin use — the ratio improves twice as fast as the individual values alone would suggest, making trends more visible. The limitation is that the same ratio value can be reached via very different routes. A ratio of 2.5 achieved by a strongly lowered LDL on a high-dose statin is fundamentally different from the same ratio achieved by a high HDL in someone who trains intensively — both are favourable, but for different reasons with different implications. Without knowing the absolute values of LDL, HDL, triglycerides, and ApoB, the context is missing. Modern preference favours ApoB (a direct count of atherogenic particles) and non-HDL cholesterol for risk estimation, because those are decoupled from fluctuations in HDL. Nevertheless, the LDL/HDL ratio is a practical indicator that is directly readable without additional calculation when reviewing a standard lipid panel.
LDL / HDL Ratio high or low — what it means
Always read the LDL/HDL ratio alongside the absolute values of LDL, HDL, triglycerides, and ApoB. Check whether a favourable ratio results from a genuinely improved profile — lower LDL with stable or higher HDL — rather than from an unfavourable change in one component that coincidentally yields a low ratio. A low ratio caused by a reduced HDL (from inactivity, smoking, or high triglycerides) is a warning sign, not reassurance. Because triglycerides influence the LDL calculation (the Friedewald formula) and high triglycerides accompany a shift toward small, dense LDL particles, the ratio is less reliable with markedly elevated triglycerides. In that case, ApoB gives a fairer picture of atherogenic burden. For tracking changes after an intervention, a retest 6–12 weeks later is appropriate — enough time for a statin or lifestyle change to show its effect in the lipid panel. Use the ratio as part of the broader story, not as a verdict on its own.
Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.
Read about our scientific approach →